JP2025516298A5 - - Google Patents

Info

Publication number
JP2025516298A5
JP2025516298A5 JP2024564817A JP2024564817A JP2025516298A5 JP 2025516298 A5 JP2025516298 A5 JP 2025516298A5 JP 2024564817 A JP2024564817 A JP 2024564817A JP 2024564817 A JP2024564817 A JP 2024564817A JP 2025516298 A5 JP2025516298 A5 JP 2025516298A5
Authority
JP
Japan
Prior art keywords
concentration
liquid pharmaceutical
stable liquid
formulation
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024564817A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025516298A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/020660 external-priority patent/WO2023215267A1/en
Publication of JP2025516298A publication Critical patent/JP2025516298A/ja
Publication of JP2025516298A5 publication Critical patent/JP2025516298A5/ja
Pending legal-status Critical Current

Links

JP2024564817A 2022-05-02 2023-05-02 抗インターロイキン-4受容体(il-4r)抗体製剤 Pending JP2025516298A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263337532P 2022-05-02 2022-05-02
US63/337,532 2022-05-02
PCT/US2023/020660 WO2023215267A1 (en) 2022-05-02 2023-05-02 Anti-interleukin-4 receptor (il-4r) antibody formulations

Publications (2)

Publication Number Publication Date
JP2025516298A JP2025516298A (ja) 2025-05-27
JP2025516298A5 true JP2025516298A5 (cg-RX-API-DMAC7.html) 2026-05-12

Family

ID=86609834

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024564817A Pending JP2025516298A (ja) 2022-05-02 2023-05-02 抗インターロイキン-4受容体(il-4r)抗体製剤

Country Status (12)

Country Link
US (1) US20240024472A1 (cg-RX-API-DMAC7.html)
EP (1) EP4518837A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025516298A (cg-RX-API-DMAC7.html)
KR (1) KR20250004863A (cg-RX-API-DMAC7.html)
CN (1) CN119136787A (cg-RX-API-DMAC7.html)
AU (1) AU2023263975A1 (cg-RX-API-DMAC7.html)
CA (1) CA3250514A1 (cg-RX-API-DMAC7.html)
CO (1) CO2024014835A2 (cg-RX-API-DMAC7.html)
IL (1) IL316264A (cg-RX-API-DMAC7.html)
MX (1) MX2024013496A (cg-RX-API-DMAC7.html)
TW (1) TW202406572A (cg-RX-API-DMAC7.html)
WO (1) WO2023215267A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025017034A1 (en) * 2023-07-17 2025-01-23 Formycon Ag Stable liquid antibody formulation for dupilumab
WO2025116637A1 (ko) * 2023-12-01 2025-06-05 삼성바이오에피스 주식회사 항-IL-4Rα 항체의 안정한 액상 제형
EP4623903A1 (en) * 2024-03-28 2025-10-01 Fresenius Kabi Deutschland GmbH Pharmaceutical composition comprising dupilumab
KR20260105275A (ko) * 2024-12-26 2026-07-06 주식회사 종근당 항-hIL-4Rα 항체를 위한 안정화된 액상 조성물

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0747045B2 (ja) 1986-10-15 1995-05-24 株式会社大協精工 積層した注射器用滑栓
WO1990005183A1 (en) 1988-10-31 1990-05-17 Immunex Corporation Interleukin-4 receptors
JP3100727B2 (ja) 1992-01-23 2000-10-23 株式会社大協精工 変性ポリシロキサン組成物及び該組成物を被覆した衛生ゴム製品
JP3172057B2 (ja) 1995-04-05 2001-06-04 株式会社大協精工 ラミネートゴム栓
JP3512349B2 (ja) 1999-01-29 2004-03-29 株式会社大協精工 柱状ゴム要素の成形型
PT2990420T (pt) 2000-05-26 2017-03-16 Immunex Corp Uso de anticorpos de recetor de interleucina-4 e composições dos mesmos
JP2002209975A (ja) 2001-01-19 2002-07-30 Daikyo Seiko Ltd 医薬バイアル用ラミネートゴム栓
UA93653C2 (ru) 2003-11-07 2011-03-10 Иммунекс Корпорейшн Выделенное антитело, kotopoe специфически связывается c человеческим рецептором il-4 (il-4r)
CA2664343C (en) 2006-10-02 2016-04-26 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human il-4 receptor
US8092804B2 (en) 2007-12-21 2012-01-10 Medimmune Limited Binding members for interleukin-4 receptor alpha (IL-4Rα)-173
MX366337B (es) * 2010-10-06 2019-07-05 Regeneron Pharma Formulaciones estabilizadas que contienen anticuerpos anti-receptor de interleucina-4 (il-4r).
JP5859148B2 (ja) * 2012-03-08 2016-02-10 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Aβ抗体製剤
EP2823841A1 (en) 2013-07-09 2015-01-14 Sanofi-Aventis Deutschland GmbH Autoinjector
RU2689145C2 (ru) * 2014-04-16 2019-05-24 Биокон Лтд. Стабильные белковые препараты, содержащие молярный избыток сорбитола
AR102198A1 (es) 2014-10-09 2017-02-08 Regeneron Pharma Proceso para reducir partículas subvisibles en una formulación farmacéutica
TW201707738A (zh) 2015-06-03 2017-03-01 賽諾菲阿凡提斯德意志有限公司 注射器支架及自動注射器(二)
TW201711716A (zh) 2015-06-03 2017-04-01 賽諾菲阿凡提斯德意志有限公司 護罩鎖
TW201709941A (zh) 2015-06-03 2017-03-16 賽諾菲阿凡提斯德意志有限公司 聲響指示器(二)
TW201711713A (zh) 2015-06-03 2017-04-01 賽諾菲阿凡提斯德意志有限公司 藥物輸送裝置(五)
TW201707741A (zh) 2015-06-03 2017-03-01 賽諾菲阿凡提斯德意志有限公司 針頭護罩之抓握器、蓋子、自動注射器及製造抓握器之方法
CN107474134B (zh) 2016-06-08 2021-07-27 苏州康乃德生物医药有限公司 用于结合白细胞介素4受体的抗体
CN110540590B (zh) 2018-05-29 2023-08-18 康诺亚生物医药科技(成都)有限公司 一种自免疫抑制物的开发和应用
MX2021001143A (es) 2018-08-24 2021-04-12 Jiangsu Hengrui Medicine Co Anticuerpo de union a il-4r humana, fragmento de union a antigeno y uso medico del mismo.
KR102330596B1 (ko) 2018-11-09 2021-11-26 아주대학교산학협력단 인간 il-4 수용체 알파에 대한 고친화도 인간 항체 및 이의 용도
CN111494626B (zh) 2018-12-25 2022-06-21 江苏荃信生物医药股份有限公司 用于治疗il-4和/或il-13介导的信号转导相关的疾病的药物组合物
SG11202107007VA (en) 2018-12-27 2021-07-29 Akeso Biopharma Inc Antibody against human il-4ra and use thereof
CN111592597B (zh) 2019-05-29 2022-04-26 山东博安生物技术股份有限公司 白介素4受体(il-4r)结合蛋白及其用途

Similar Documents

Publication Publication Date Title
JP6456470B2 (ja) 抗pcsk9抗体を含む安定化製剤
KR102667484B1 (ko) 안정한 항체 제형
JP6396565B2 (ja) 抗インターロイキン−4受容体(il−4r)抗体を含有する安定化製剤
US12559551B2 (en) Stabilized formulations containing anti-ANGPTL3 antibodies
CN102458469B (zh) 人抗TNF-α抗体的稳定高蛋白质浓度制剂
JP2016020371A (ja) 抗インターロイキン6受容体(il−6r)抗体を含有する安定化製剤
JP2022526292A5 (cg-RX-API-DMAC7.html)
US20220202937A1 (en) Novel Formulations Which Stabilize Low Dose Antibody Compositions
JP2023511080A (ja) 安定な抗体製剤
AU2024372916A1 (en) Stable antibody formulation comprising fianlimab
TWI498121B (zh) 含有抗-介白素-4受體(il-4r)抗體之安定化配製物
JP2023533963A5 (cg-RX-API-DMAC7.html)
RU2024135750A (ru) Составы антитела к рецептору интерлейкина-4 (il-4r)
CN115812080A (zh) 含有抗ctla-4抗体的稳定调配物
CN121360224A (zh) 一种抗tslp抗体药物组合物及其用途
EA047546B1 (ru) Стабилизированные составы, содержащие антитела анти-pcsk9